A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

NCT00683930 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Pemphigus Vulgaris (PV)

Interventions

DRUG: Mycophenolate Mofetil 2 g/Day
DRUG: Mycophenolate Mofetil (MMF) 3 g/Day
DRUG: Placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]